Cipralex®/Lexapro®/Seroplex®/Sipralexa®

PrintIncrease text size

How does it work
Cells in the brain communicate with each other via electric signals and by using messenger substances, called “neurotransmitters”. One of these messengers is called serotonin. It has been shown that a certain messenger level is required to maintain good communication between the cells of the central nervous system. If there are too few neurotransmitters, communication is disrupted, which causes the symptoms of depression and anxiety.

These messenger substances are usually “recycled” after they have done their work in the brain. So-called “serotonin transporters” act like small vacuum cleaners to collect these messengers so they can be used again later. A special class of medications, the “Selective Serotonin Reuptake Inhibitors (SSRI)” have been designed to block the transporters so that the messengers can work a little longer and more efficiently, than normal.

Escitalopram, the active ingredient of Cipralex / Lexapro, is an optimized SSRI as it blocks the transporter at two different locations. That makes it the most efficient known compound of its kind. By efficiency, we mean that it makes sufficient serotonin available, so that nervous-system cells can once again communicate with each other. This, in turn, reduces the symptoms of depression and anxiety.

Cipralex® in depression
In a variety of clinical trials, escitalopram (Cipralex®) has been demonstrated to effectively treat major depressive disorders in both the short- and long-term, and is well tolerated by patients.

Please refer to your local prescribing information to find out about the current approval situation for escitalopram in your country. If you are a patient and have further questions about Cipralex®, please ask your pharmacist or physician. If you are a healthcare professional, please refer to the specific section of this website we have created for you.

Cipralex® in Anxiety Disorders
In a variety of clinical trials, escitalopram (Cipralex®) has been demonstrated to effectively treat major depressive disorders in both the short- and long-term, and is well tolerated by patients. Cipralex® is currently approved for the treatment of Panic Disorder, with or without agoraphobia (the fear to enter open places), Generalized Anxiety Disorder, Social Anxiety Disorder and Obsessive-Compulsive-Disorder.

Please refer to your local prescribing information to find out about the current approval situation for escitalopram in your country. If you are a patient and have further questions about Cipralex®, please ask your pharmacist or physician. If you are a healthcare professional, please refer to the specific section of this website we have created for you.

Hyperlinks for professionals:

The Lundbeck Institute
http://www.cnsforum.com

The Collegium Internationale Neuro Psychopharmacologicum
http://www.cinp.org/

The American Psychiatric Association
http://www.psych.org/

iFred, The International Foundation for Research and Education on Depression
http://www.ifred.org/

The World Federation of Societies of Biological Psychiatry
http://www.wfsbp.org/

Depression

Depression is a genuine physical condition. The symptoms of depression, such as feeling sad or tired of everything, and those of anxiety, such as the inability to make decisions and worrying about trivial things, are well described. However, people suffering from depression must also deal with social prejudice and stigmatisation. Read more here

 
H. Lundbeck A/S
Ottiliavej 9
DK-2500 Copenhagen Valby
Tel +45 36 30 13 11
Fax +45 36 30 19 40
information@lundbeck.com
Contact us
The specialist in psychiatry and pioneer in neurology
Disclaimer & Privacy statement